Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-10-30Clinical Trial Update: Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir FDC and Ribavirin in Participants With Chronic Genotype 3 HCV Infection and Cirrhosis [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of Sofosbuvir/Velpatasvir fixed-dose combination with and without Ribavirin in adu…
-
CLINICAL_TRIALS trial_result · 2018-10-30Clinical Trial Update: Chronic Hepatitis C Treatment in Egyptian Children With Gaucher Disease. [Phase 4]
A Phase 4 clinical trial evaluating chronic hepatitis C treatment in Egyptian children with Gaucher disease is ongoing, with status currentl…
-
CLINICAL_TRIALS trial_result · 2018-10-26Clinical Trial Update: Efficacy and Safety of MP-424, Interferon Beta (IFN Beta), and Ribavirin(RBV) in Treatment-Naïve or Having Received Interferon Based Therapy With Chronic Hepatitis C (CHC) [Phase 3]
Phase 3 trial evaluating the efficacy and safety of MP-424 combined with Interferon Beta and Ribavirin in treatment-naïve or interferon-expe…
-
CLINICAL_TRIALS trial_result · 2018-10-25Clinical Trial Update: Effects of Harvoni in Patients With Decompensated Cirrhosis Due to Hepatitis C Genotype 1 Infection [Phase 3]
Phase 3 trial update evaluating Harvoni in patients with decompensated cirrhosis due to Hepatitis C genotype 1; study completed.
-
FDA approval · 2018-10-23FDA Approved: SOVALDI — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for Sovaldi (sofosbuvir) submitted by Gilead Sciences, Inc. The approval updates the product lab…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-10-23Clinical Trial Update: A Study Evaluating Slow Response/Non-Rapid Response in Patients With Chronic Hepatitis C, Genotype 1, 2, 3 & 4 Treated With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) [Phase 4]
Phase 4 trial assessing slow or non-rapid response in chronic hepatitis C patients treated with pegylated interferon alfa-2a and ribavirin; …
-
CLINICAL_TRIALS trial_result · 2018-10-18Clinical Trial Update: A Study to Investigate HCV Response Rates in Real World Patients: HEARTLAND Study [Phase 4]
Phase 4 study update evaluating hepatitis C response rates in real-world patients.
-
CLINICAL_TRIALS trial_result · 2018-10-17Clinical Trial Update: Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir, Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C
A real-world evidence study evaluating the effectiveness of Paritaprevir/Ritonavir, Ombitasvir, with or without Dasabuvir and Ribavirin in c…
-
CLINICAL_TRIALS trial_result · 2018-10-12Clinical Trial Update: Evaluate the Efficacy and Safety of TG-2349 in Subjects With Hepatitis C Infection [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of TG-2349 in adults with chronic hepatitis C has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-10-11Clinical Trial Update: Sofosbuvir/Ledipasvir for Hepatitis C Genotype 1-6 in Patients With Transfusion-Dependent Thalassemia: An Open Label Trial [Phase 4]
Phase 4 open-label trial assessing Sofosbuvir/Ledipasvir for Hepatitis C in patients with transfusion-dependent thalassemia has completed.
-
CLINICAL_TRIALS trial_result · 2018-10-09Clinical Trial Update: Efficacy, Safety, and Tolerability of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Participants Who Switch to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) or Emtricitabine/Rilpivirine/Tenofovir Alafenamide (F/R/TAF) Prior to LDV/SOF HCV Treatment [Phase 3]
Phase 3 trial update evaluating the efficacy, safety, and tolerability of LDV/SOF treatment for HIV/HCV co-infected participants who switch …
-
CLINICAL_TRIALS trial_result · 2018-10-09Clinical Trial Update: ABT-450/Ritonavir/ ABT-267 (ABT-450/r/ABT-267) and ABT-333 Co-Administered With Ribavirin (RBV) in Treatment Naïve and Treatment Experienced Asian Adults With Genotype 1b Chronic Hepatitis C Virus (HCV) Infection and Compensated Cirrhosis [Phase 3]
Phase 3 trial update of ABT-450/r/ABT-267 plus ABT-333 with ribavirin in treatment-naïve and experienced Asian adults with genotype 1b chron…
-
CLINICAL_TRIALS trial_result · 2018-09-27Clinical Trial Update: Evaluation of Unipeg® for Response and Ongoing Safety in Pakistani Population [Phase 4]
Phase 4 trial evaluating Unipeg® for response and ongoing safety in the Pakistani population with hepatitis C completed; results posted in 2…
-
CLINICAL_TRIALS trial_result · 2018-09-21Clinical Trial Update: DAA-based Therapy for Recently Acquired Hepatitis C II (DAA = Directly Acting Antiviral) [Phase 4]
Phase 4 trial update on direct-acting antiviral therapy for recently acquired hepatitis C; study completed.
-
CLINICAL_TRIALS trial_result · 2018-09-20Clinical Trial Update: Statins in Chronic Hepatitis C Patients Receiving Sofosbuvir/Daclatasvir Combination [Phase 2, Phase 3]
A study evaluating the safety and efficacy of statins in patients with chronic hepatitis C undergoing sofosbuvir/daclatasvir therapy, comple…
-
CLINICAL_TRIALS trial_result · 2018-09-17Clinical Trial Update: Efficacy and Safety of Zoval (Sofosbuvir) and Ribavirin With or Without Interferon [Phase 4]
Phase 4 trial update on the efficacy and safety of Sofosbuvir (Zoval) with or without Ribavirin and Interferon in chronic hepatitis C.
-
CLINICAL_TRIALS trial_result · 2018-09-17Clinical Trial Update: A Study of the Pharmacokinetics of Uprifosbuvir (MK-3682) and Ruzasvir (MK-8408) in Participants With Moderate and Severe Hepatic Insufficiency (MK-3682-029) [Phase 1]
Phase 1 pharmacokinetic study assessing uprifosbuvir and ruzasvir in participants with moderate to severe hepatic impairment completed with …
-
CLINICAL_TRIALS trial_result · 2018-09-13Clinical Trial Update: Single and Multiple Dose Study of Uprifosbuvir (MK-3682/IDX21437) in Healthy and Hepatitis C Virus (HCV)-Infected Participants (MK-3682-001) [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating single and multiple doses of Uprifosbuvir in healthy participants and those with chronic hepatitis C; co…
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: Swiss HCVree Trial [Phase 3]
Phase 3 clinical trial completed for an intervention targeting Hepatitis C and HIV.
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: Ledipasvir/Sofosbuvir Treatment for Hepatitis C in HCT Recipients. [Phase 4]
Phase 4 trial update for ledipasvir/sofosbuvir in hematopoietic stem cell transplant recipients has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-08-27Clinical Trial Update: Serum Alpha-fetoprotein Levels and Response to Direct Antiviral Therapy in Patients With Chronic Hepatitis C [Phase 4]
Phase 4 trial update examining serum alpha-fetoprotein levels and response to direct antiviral therapy in chronic hepatitis C patients.
-
CLINICAL_TRIALS trial_result · 2018-08-21Clinical Trial Update: Sofosbuvir/Velpatasvir Fixed Dose Combination in Participants With Chronic Hepatitis C Virus Infection Who Have Received a Liver Transplant [Phase 2]
Phase 2 trial evaluating Sofosbuvir/Velpatasvir fixed-dose combination in liver transplant recipients with chronic hepatitis C; study comple…
-
CLINICAL_TRIALS trial_result · 2018-08-10Clinical Trial Update: Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection [Phase 2]
Phase 2 clinical trial update on liver cancer prevention in patients with chronic hepatitis C infection has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-08-08Clinical Trial Update: Sofosbuvir Plus Ribavirin, or Ledipasvir/Sofosbuvir in Adults With HCV Infection and Renal Insufficiency [Phase 2]
Phase 2 trial comparing Sofosbuvir plus Ribavirin versus Ledipasvir/Sofosbuvir in adults with hepatitis C and renal insufficiency; results p…
-
CLINICAL_TRIALS withdrawal · 2018-08-07Clinical Trial Update: A Single-arm Evaluation of the Effect of HCV Treatment on Cardiovascular Disease Risk [Phase 4]
A Phase 4 single-arm study evaluating the effect of hepatitis C treatment on cardiovascular disease risk has been withdrawn.